ASCCT Webinars

Upcoming Webinars

Webinars are available for all to attend and watch at no cost. However, after the event the videos are only available to ASCCT members.

Wed, July 24, 2019
10:00 AM - 11:00 AM EDT

Using Quantitative Systems Toxicology (QST): Improving the safety of drugs while reducing animal testing
Presenter: Paul B. Watkins, M.D.
Director, Institute for Drug Safety Sciences, Schools of Pharmacy, Medicine, and Public Health, University of North Carolina – Chapel Hill

Registration link: https://attendee.gotowebinar.com/register/1428823456128168460

September 17, 2019
11:00 AM - 12:00 PM EDT

Nerve-on-a-Chip Platform for Assessing Chemotherapy-induced Peripheral Neuropathy

Presenter: Lowry Curley, AxoSim,Inc

Registration link: https://attendee.gotowebinar.com/register/8913693886943624459

Archived Webinars

Archived videos of past webinars are available to ASCCT members. Contact the Secretary for more information or to suggest a topic for a future webinar.


ASCCT & ESTIV GARD™air Webinar (June 2019) (June 2019)

GARD™air - An in vitro assay to test for respiratory sensitizers using genomic biomarkers and machine learning

Presenter: Joshua Schmidt, SenzaGen Inc., USA
Co-author: Andy Forreryd, SenzaGen AB, Lund, Sweden


EPA computational tools (May 2019)

New Computational Tools from EPA:
The CompTox Chemicals Dashboard and Generalized Read Across
Presenters: Antony Williams and Grace Patlewicz, EPA


Automated and Integrated Analysis Workflow for Adverse Outcome Pathway Identification, Hypothesis Generation and Risk Assessment (April 2019)

Presenters:
Noffisat O. Oki (1) and Tatyana Doktorova (2)
1Edelweiss Connect Inc, Durham, NC, USA
2Edelweiss Connect Gmbh, Basel, Switzerland


Advancing tools for predictive toxicology (March 2019)

Title: Establishment of bile duct tubular structure mimicking the intrahepatic bile duct morphogenesis for an in vitro bile recovery
Presenters: Astia Rizki-­‐Safitri, Marie Shinohara, Minoru Tanaka, and Yasuyuki Sakai

Title: Generation of recombinant human anti-diphtheria toxin neutralizing antibody to replace equine sera
Presenters: Esther Wenzel, Paul Stickings, Jeffrey Brown, Thea Sesardic, Androulla Efstratiou, Michael Hust

Title: Development and Use of Adverse Outcome Pathway (AOP) Networks to Support Assessment of Organ Level Effects
Presenters: Nicoleta Spinu, Mark TD Cronin, Steven J. Enoch, and Judith C Madden


Combining biological and computational approaches (February 2019)

Presenter 1: Daniel Russo, Rutgers University
Title: Developing Mechanism-Based Animal Toxicity Models: A Chemocentric Approach Using Big Data

Presenter 2: Sudin Bhattacharya, Michigan State University
Title: Integrating Genomics and Epigenomics into Predictive Toxicology of the AH Receptor


Nanoceramic pulmonary toxicity & reproducible cell line technology (January 2019)

Award Winners Series: Nanoceramic pulmonary toxicity & reproducible cell line technology
Jan 23, 2019 10:00 AM EST

Presenter 1: Maria João Bessa, PhD candidate, Portuguese National Institute of Health
Title: Pairwise toxicity evaluation of ceramic nanoparticles exposure in human alveolar epithelial A549 cells at submerged and air-liquid cultures

Presenter 2: Tom Wahlicht, PhD, InSCREENeX GmbH
Title: Reproducible in vitro toxicology testing using functional immortalized cells


Development of In Vitro Toxicology Assays using Human Pluripotent Stem Cells and Targeted Metabolomics (December 2018)

Dec 13, 2018 2:00 - 3:00 PM EST

Jessica A. Palmer, Stemina Biomarker Discovery, Inc. 


Thorough QT-QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc Relationships (November 2018)

Presenter: Weihsueh A. Chiu, PhD, Texas A&M University


Stem Cell-Based in Vitro Models: State-of-the-Art Tools to Predict Drug-Induced Tissue Injury in Humans (October 2018)

Presenter: Prof. Joery De Kock, Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel


Adverse Outcome Pathways: An update on progress and some near-term applications (September 2018)

Presenters:
Kristie Sullivan (1) and Mathieu Vinken (2)

1 Physicians Committee for Responsible Medicine, Washington, DC
2 Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Belgium.